Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucose transporters in brain in health and disease
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1299-1343
Open Access | Times Cited: 375

Showing 1-25 of 375 citing articles:

Neuroprotective Effect of SGLT2 Inhibitors
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7213-7213
Open Access | Times Cited: 162
Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle
Jens V. Andersen, Arne Schousboe, Alexei Verkhratsky
Progress in Neurobiology (2022) Vol. 217, pp. 102331-102331
Closed Access | Times Cited: 149
Energy matters: presynaptic metabolism and the maintenance of synaptic transmission
Sunan Li, Zu‐Hang Sheng
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 4-22
Closed Access | Times Cited: 138
Intranasal Insulin for Alzheimer’s Disease
Manfred Hallschmid
CNS Drugs (2021) Vol. 35, Iss. 1, pp. 21-37
Open Access | Times Cited: 109
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
Raluca Ioana Teleanu, Manuela Daniela Preda, Adelina-Gabriela Niculescu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 987-987
Open Access | Times Cited: 109
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
Maria Rosaria Rizzo, Irene Di Meo, Rita Polito, et al.
Pharmacological Research (2022) Vol. 176, pp. 106062-106062
Open Access | Times Cited: 101
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 58
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
Zhaojun Wang, Xinru Li, Shi-Fan Chai, et al.
Neuropharmacology (2023) Vol. 240, pp. 109716-109716
Closed Access | Times Cited: 42
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
Haruka Tsubaki, Ikuo Tooyama, Douglas G. Walker
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9357-9357
Open Access | Times Cited: 104
A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
Natalia Kyrtata, Hedley Emsley, Oli Sparasci, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 102
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 98
Energy Metabolism Decline in the Aging Brain—Pathogenesis of Neurodegenerative Disorders
Janusz Błaszczyk
Metabolites (2020) Vol. 10, Iss. 11, pp. 450-450
Open Access | Times Cited: 86
In situ growth of TiO2 nanowires on Ti3C2 MXenes nanosheets as highly sensitive luminol electrochemiluminescent nanoplatform for glucose detection in fruits, sweat and serum samples
Yan Sun, Peipei Li, Yu Zhu, et al.
Biosensors and Bioelectronics (2021) Vol. 194, pp. 113600-113600
Closed Access | Times Cited: 86
Functions of amyloid precursor protein in metabolic diseases
Yanjun Guo, Qinqiu Wang, Shenghui Chen, et al.
Metabolism (2020) Vol. 115, pp. 154454-154454
Closed Access | Times Cited: 73
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 6, pp. 745-766
Open Access | Times Cited: 61
Glucose metabolism and AD: evidence for a potential diabetes type 3
Andrea González, Camila Calfío, Macarena Churruca, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease
Qianqian Wang, Linyan Duan, Xingfan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4351-4351
Open Access | Times Cited: 59
Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
Elena Puris, Gert Fricker, Mikko Gynther
Pharmaceutical Research (2022) Vol. 39, Iss. 7, pp. 1415-1455
Open Access | Times Cited: 56
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 54
A High-Sugar Diet Consumption, Metabolism and Health Impacts with a Focus on the Development of Substance Use Disorder: A Narrative Review
Kacper Witek, Karolina Wydra, Małgorzata Filip
Nutrients (2022) Vol. 14, Iss. 14, pp. 2940-2940
Open Access | Times Cited: 47
Brain capillary pericytes are metabolic sentinels that control blood flow through a KATP channel-dependent energy switch
Ashwini Hariharan, Colin D. Robertson, Daniela C.G. Garcia, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111872-111872
Open Access | Times Cited: 41
Astrocyte metabolism and signaling pathways in the CNS
Yong-Mei Zhang, Yingbei Qi, Ya-nan Gao, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 36
How Can Insulin Resistance Cause Alzheimer’s Disease?
Ji Hye Yoon, JooHyun Hwang, Sung Un Son, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3506-3506
Open Access | Times Cited: 34
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
Zheng Shen, Zhengyang Li, Mengting Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114206-114206
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top